Leptospirosis Market, by Drug (Amoxicillin, Azithromycin, Cefixime, Doxycycline, Others (Ceftriaxone,Penicillin among others)), by Diagnosis (Complete Blood Count (CBC), Creatine Kinase, Liver Enzymes, Urinalysis, Others (Lumbar puncture, Microscopic agglutination test among others)), by Route of Administration (Oral, Parenteral, Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023

Code : CMI5761

Pages :339

Formats :

Excel and PDF

Industry : Pharmaceutical

Leptospirosis MarketSize and Trends

The global leptospirosis market is estimated to be valued at US$ 496.8 million in 2023 and is expected to exhibit a CAGR of 5.8% during the forecast period (2023-2030).

Figure 1. Global Leptospirosis Market Share (%), By Drug, 2023

Global Leptospirosis Market Segmentation:

The global leptospirosis market report is segmented into Drug, Diagnosis, Route of Administration, and Distribution Channel

Based on Drug, the market is segmented into amoxicillin, azithromycin, cefixime, doxycycline, and others (ceftriaxone, penicillin among others). Out of which, the amoxicillin segment is expected to dominant position in global leptospirosis market during the forecast period and this is attributed due to the increase in the use of Amoxicillin for the treatment of Leptospirosis based on guidelines published by government authorities.

Based on Diagnosis, the market is segmented into complete blood count (CBC), creatine kinase, liver enzymes, urinalysis, and others which include lumbar puncture, microscopic agglutination test, and others. Out of which, completed blood count (CBC) segment is expected to dominate the market over the forecast period.

Based on Route of Administration, the market is segmented into oral, parenteral, and intravenous. Out of which, oral segment is expected to dominate the market over the forecast period and this is attributed to the increased use of antibiotics for the treatment of leptospirosis.

Based on Distribution Channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Out of which, hospital pharmacies segment is expected to dominate the market over the forecast period and this is attributed to the increase in the number of hospital pharmacies.

Based on Region, Africa is expected to hold a dominant position in the market among all the regions due to increasing awareness programs in the regions for leptospirosis for early detection and treatment

Among all segmentation, drug segment has the highest potential due to the increasing use of off-label antibiotics for the treatment of leptospirosis as there is no approved product by regulatory authorities available in the market.